The Evolution of BioSense: Lessons Learned and Future Directions.

Area of Science:

• Public Health
• Epidemiology
• Biodefense Surveillance

Background:

• The BioSense program was initiated in 2003 to create a national integrated public health surveillance system.
• Its initial focus was on detecting bioterrorism-related illnesses, with a centralized approach.
• The program has since evolved to emphasize state and local syndromic surveillance capacity.

Purpose of the Study:

• To describe the evolution of the BioSense program and its transition to the National Syndromic Surveillance Program.
• To highlight the expanding applications of syndromic surveillance beyond bioterrorism.
• To outline future directions for enhancing public health surveillance capabilities.

Main Methods:

• Programmatic review and analysis of the BioSense program's development and strategic shifts.
• Examination of the evolving uses of syndromic surveillance data.
• Description of future program development plans.

Main Results:

• The BioSense program has transitioned from a CDC-centric model to a decentralized, state and local focus.
• Syndromic surveillance applications have broadened from bioterrorism alerts to situational awareness for diverse public health events.
• Future plans emphasize data quality, system capacity, innovation, and new data sources.

Conclusions:

• The National Syndromic Surveillance Program represents a mature and adaptable public health surveillance system.
• Continuous improvement in data quality and system functionality is crucial for effective public health monitoring.
• The program's future aims to leverage innovation and emerging technologies for enhanced disease detection and response.